Applied Health Economics and Health Policy

Papers
(The H4-Index of Applied Health Economics and Health Policy is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil158
Cost-Effectiveness of a Universal School-Based Mental Health Prevention Program: An Economic Modeling Study in a Limited Income Context86
Population Norms for SF-6Dv2 and EQ-5D-5L in China41
Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview Study39
Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach38
Improving Consumer Engagement in Health Technology Assessment and Decision Making: Lessons from ‘Values in Science’35
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China30
Assessing the Direct Impact of Death on Discrete Choice Experiment Utilities29
Cost-Effectiveness of Perinatal Depression Screening: A Scoping Review29
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework24
Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?24
Therapy, Pills and Unmet Needs for Financial Reasons: Socioeconomic Inequalities and Inequities in Access to Mental Health Care in Spain 2014–202024
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions23
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines23
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand23
Selection and Prioritization of Medical Devices for HTA Evaluation: A Systematic Review of Existing Approaches23
The Economics of Antibiotic Resistance: A Systematic Review and Meta-analysis Based on Global Research22
A Guideline-Implementation Intervention to Improve the Management of Low Back Pain in Primary Care: A Difference-in-Difference-in-Differences Analysis20
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable?19
Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom19
0.049209833145142